Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antagonist activity at recombinant human QRFP receptor expressed in CHO cells preincubated for 10 mins followed by agonist challenge in presence of probenecid by Fluo-4AM staining based fluorescence assay
Assay data:2 Tested
SummaryPubMed CitationRelated BioAssays by Target
Displacement of [125I]-43RFa from human QRFP receptor expressed in CHO cells by TopCount scintillation counting method
Assay data:1 Active, 1 Activity ≤ 1 µM, 11 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
PRESTO-Tango GPCRome screening (QRFP)
Assay data:1 Tested
SummaryRelated BioAssays by Target
GPR103 Eurofins-Panlabs selectivity data (BI)
Displacement of [125I]-43RFa from human QRFP receptor expressed in CHO cell membrane by TopCount scintillation counter method
Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization at 10 uM preincubated for 30 mins followed by agonist addition measured after 3 mins by Fluo-4 AM-based scanning fluorometery
Assay data:1 Active, 2 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization at 100 uM preincubated for 15 mins followed by agonist addition measured after 3 mins by Fluo-4 AM-based scanning fluorometery relative to 26RFa (20 to 26 residues)
Assay data:3 Tested
Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubated for 15 mins followed by agonist addition measured after 3 mins by Fluo-4 AM-based scanning fluorometery
Assay data:3 Active, 1 Activity ≤ 1 µM, 35 Tested
Agonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as increase Ca2+ mobilization after 3 mins by Fluo-4 AM-based scanning fluorometery
Assay data:9 Active, 3 Activity ≤ 1 µM, 36 Tested
Mouse QRFP receptor (QRFP receptor)
Assay data:5 Active, 5 Tested
Rat QRFP receptor (QRFP receptor)
Assay data:1 Active, 1 Tested
Human QRFP receptor (QRFP receptor)
Assay data:6 Active, 6 Tested
Displacement of [125I]QRFP43 from human GPR103 receptor expressed in HEK cells after 90 mins incubation by scintillation counting
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
Inhibition of human GPR103 receptor expressed in CHOK1 cells by IP-1 assay
Assay data:12 Active, 9 Activity ≤ 1 µM, 14 Tested
Displacement of [125I]-QRFP43 from human GPR103 receptor overexpressed in HEK membranes after 90 mins by liquid scintillation counting
Assay data:19 Active, 10 Activity ≤ 1 µM, 22 Tested
Antagonist activity at human GPR103 receptor assessed as inhibition of inositol-1-phosphate production by cell-based assay
Assay data:25 Active, 15 Activity ≤ 1 µM, 30 Tested
Agonist activity at human GPR103 expressed in CHO cells co-expressing Galpha16 assessed as increase in intracellular calcium level measured for 2 mins by fluorimetry
Assay data:13 Active, 9 Activity ≤ 1 µM, 18 Tested
Displacement of [125I]26RFa from human GPR103 expressed in HEK293 cells incubated for 1 h by gamma counter based method
Assay data:4 Active, 1 Activity ≤ 1 µM, 4 Tested
Antagonist activity at human GPR103 expressed in CHO cells co-expressing Galpha16 assessed as inhibition of human 26RFa-induced increase in intracellular calcium level by fluorimetry
Assay data:14 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on